07/01/2025
3:40 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
3:25 PM | Cole Douglas G. (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
3:26 PM | Biller Scott (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
3:27 PM | Foghorn Therapeutics (Issuer)
GILL SIMBA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
3:28 PM | Foghorn Therapeutics (Issuer)
Lynch Thomas J. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
3:28 PM | Foghorn Therapeutics (Issuer)
Mendelsohn Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
3:29 PM | Foghorn Therapeutics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
3:29 PM | Foghorn Therapeutics (Issuer)
SMITH IAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:05 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:07 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
7:00 AM | Foghorn Therapeutics (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for FHTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/05/2025
7:05 AM | Foghorn Therapeutics (Filer)
| Form DEFA14A | |
05/05/2025
7:10 AM | Foghorn Therapeutics (Filer)
| Form ARS | |
05/02/2025
3:03 PM | Duty Stuart (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:04 PM | Foghorn Therapeutics (Issuer)
Gallagher Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:01 PM | Foghorn Therapeutics (Issuer)
GOTTSCHALK ADRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:31 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
3:25 PM | Foghorn Therapeutics (Filer)
| Form 424B5 | |
03/06/2025
3:08 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
8:28 AM | FMR LLC (Filed by)
Foghorn Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
6:00 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2025
11:15 PM | Foghorn Therapeutics (Filer)
| Form EFFECT | |
01/24/2025
3:11 PM | Foghorn Therapeutics (Issuer)
Rivkin Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:13 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:15 PM | Foghorn Therapeutics (Issuer)
Humer Kristian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:16 PM | Cardama Alfonso Quintas (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:05 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:54 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:54 AM | Foghorn Therapeutics (Issuer)
Koppel Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
6:15 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
4:44 PM | Foghorn Therapeutics (Subject)
Klarman Family Foundation (Filed by)
| Form SC 13G/A | |
09/24/2024
3:01 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:00 PM | Flynn James E (Filed by)
Foghorn Therapeutics (Subject)
| Form SC 13G | |
09/18/2024
3:01 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:40 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:00 PM | Bellon Steven F. (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:31 PM | Bellon Steven F. (Reporting)
Foghorn Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
7:44 AM | Foghorn Therapeutics (Filer)
| Form 424B5 | |
08/08/2024
6:02 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad) Something extraordinary is happening in Washington.
For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations.
I'm talking about a $150 trillion American asset that's scattered across all 50 states.
While the mainstream media focuses on political theater, this story is quietly developing behind closed doors. We recently interviewed Rickards to get the full story and understand how everyday Americans can pre |
